Descriere YEO:
Pe YEO găsești The Zyprexa Papers, Hardcover/Gottstein Jim de la Samizdat Health Writer\'s Co-Operative Inc,, în categoria Foreign Books.
Indiferent de nevoile tale, The Zyprexa Papers, Hardcover/Gottstein Jim din categoria Foreign Books îți poate aduce un echilibru perfect între calitate și preț, cu avantaje practice și moderne.
Preț: 193.99 Lei
Caracteristicile produsului The Zyprexa Papers, Hardcover/Gottstein Jim
- Brand: Samizdat Health Writer\'s Co-Operative Inc,
- Categoria: Foreign Books
- Magazin: elefant.ro
- Ultima actualizare: 13-07-2026 00:25:33
Comandă The Zyprexa Papers, Hardcover/Gottstein Jim Online, Simplu și Rapid
Prin intermediul platformei YEO, poți comanda The Zyprexa Papers, Hardcover/Gottstein Jim de la elefant.ro rapid și în siguranță. Bucură-te de o experiență de cumpărături online optimizată și descoperă cele mai bune oferte actualizate constant.
Descriere magazin:
On December 17, 2006, The New York Times began a series of front-page stories about documents obtained from Alaska lawyer Jim
Gottstein, showing Eli Lilly had concealed that its top-selling drug caused diabetes and other life-shortening metabolic problems. The "
Zyprexa Papers," as they came to be known, also showed Eli Lilly was illegally promoting the use of
Zyprexa on children and the elderly, with particularly lethal effects. Although Mr.
Gottstein believes he obtained the
Zyprexa Papers legally, the United States District Court for the Eastern District of New York in Brooklyn decided he had conspired to steal the documents, and Eli Lilly threatened Mr.
Gottstein with criminal contempt charges. In The Zyprexa
Papers , Mr. Gottstein gives a riveting first-hand account of what really happened, including new details about how a small group of psychiatric survivors spread the Zyprexa Papers on the Internet untraceably. All of this within a gripping, plain-language explanation of complex legal maneuvering and his battles on behalf of Bill Bigley, the psychiatric patient whose ordeal made possible the exposure of the Zyprexa Papers.